Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2004
06/30/2004EP0862628B1 Receptor and nucleic acid molecule encoding said receptor
06/30/2004EP0851876B1 Antisecretory factor peptides regulating pathological permeability changes
06/30/2004EP0848756B1 Materials and methods relating to the attachment and display of substances on cell surfaces
06/30/2004EP0845048B1 Nucleic acid detection of hepatitis gb virus
06/30/2004EP0815125B1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES
06/30/2004EP0766742B1 Regulated expression of heterologous genes in plants and transgenic fruit with a modified ripening phenotype
06/30/2004EP0724643B1 Endosomolytically active particles
06/30/2004EP0722488B1 Synthesis of catechol from biomass-derived carbon sources
06/30/2004EP0686161B1 Novel human beta2 integrin alpha subunit
06/30/2004EP0633939B1 Nisins
06/30/2004EP0584167B1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
06/30/2004EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus
06/30/2004EP0527788B1 Hepatitis c virus protease
06/30/2004CN1509429A Temperature control method and apparatus for driving polymerize chain reaction (PCR) Chip
06/30/2004CN1509338A Universal multi-variant detection system
06/30/2004CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene
06/30/2004CN1509336A Process for producing peptide
06/30/2004CN1509334A Transformant producing PF1022 substance derivatives, process for producing same and novel/biosynthesis gene
06/30/2004CN1509333A Novel neurotrophic factors
06/30/2004CN1509332A Inflammatory inhibiting factor Fwa116
06/30/2004CN1509330A Polypeptides having cellobiase activity and polynucleotides encoding same
06/30/2004CN1509329A Phosphotriesterase from agrobaterium radiobacter P230
06/30/2004CN1509328A Use of opg ligand to modulate immune response
06/30/2004CN1509293A Expression technology for proteins containing hybrid isotype antibody moiety
06/30/2004CN1509292A Combination apparoach to treatment of cancer using C-MYC antisense oligomer
06/30/2004CN1508546A Method for detecting antiacid bacteria using ribosome RNA as target
06/30/2004CN1508267A Molecule for early diagnosis of hepatocellular carcinoma
06/30/2004CN1508254A Phasmid display carrier pCANTAB5L
06/30/2004CN1508253A Hybrid expression of Neisseria protein
06/30/2004CN1508252A Use of orychophragmus violaceus ODREB2B gene for cultivating drought-tolerant plant
06/30/2004CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof
06/30/2004CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof
06/30/2004CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof
06/30/2004CN1508248A Tumour related gene and use thereof
06/30/2004CN1508155A Anti CD52 monoclonal antibody, coding sequence and use thereof
06/30/2004CN1508151A Gclq receptor, HIV-laplzo area jointed with same and relative peptide and target-directional antibody
06/30/2004CN1508143A Contruction of cDNA library of cell differential expression using LCM technology and rat testicular specific gene RSD-6 cloning and biolobical function
06/30/2004CN1508142A Human Testicular specific gene VCX-8r and VCY coding protein biological function
06/30/2004CN1508141A Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof
06/30/2004CN1155715C Improved transformation method for plants
06/30/2004CN1155714C Antifungal proteins, DNA coding therefore, and hosts incorporating same
06/30/2004CN1155713C Process for selection of transgenic plant cells
06/30/2004CN1155712C Process for preparing enzyme encoded by cephalosporin acetylthydrolase gene
06/30/2004CN1155711C Process for preparing 0-acetylsering, L-cysteine and L-cystein-related products
06/30/2004CN1155710C Recombinant herpesvirus with the use of gB Gene promoter
06/30/2004CN1155709C Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof
06/30/2004CN1155708C DNA of encoding plasminogen excited protein
06/30/2004CN1155707C Vaccines for plague
06/30/2004CN1155706C Method for treating amyotrophic lateral sclerosis
06/30/2004CN1155705C Genetic modified encoded snowderop agglutinant DNA sequence and aphid-resisting, transgenic plant
06/30/2004CN1155704C Specific augmentation primer and its method of labelling wheat macromolecular glutelin subunit
06/30/2004CN1155703C A process for preparing an anti-oxidant
06/30/2004CN1155702C Glutaminase, gene thereof and process for producing same
06/30/2004CN1155700C Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
06/30/2004CN1155616C Human protein with cancer cell growth promoting function and its coding sequence
06/30/2004CN1155615C Human protein with cancer cell growth suppressing function and its coding sequence
06/30/2004CN1155614C Human protein with cancer cell growth suppressing function and its coding sequence
06/30/2004CN1155613C Human tumor associated gene in 1-zone 3-band 3-subband of short arm of human chromosome No. 17 and its coding protein
06/30/2004CN1155609C Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
06/30/2004CN1155407C Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine
06/29/2004US6756527 Inbred corn plant 5750 and seeds thereof
06/29/2004US6756526 Drought tolerant plants and methods of increasing drought tolerance in plants
06/29/2004US6756525 By transforming plant with recombinant vector carrying choline oxidase encoding gene
06/29/2004US6756524 Nucleotide sequences coding polypeptide for use in controling fruit size and cell division in plants
06/29/2004US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain
06/29/2004US6756495 Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation
06/29/2004US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome
06/29/2004US6756484 IGF-I purification process
06/29/2004US6756483 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
06/29/2004US6756481 IL-23 receptor binding compositions
06/29/2004US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
06/29/2004US6756478 Polypeptide for use in diagnosis and treatment of infections
06/29/2004US6756404 Autoinducer compounds
06/29/2004US6756357 Variants of human ciliary neurotrophic factor (hCNTF)
06/29/2004US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine
06/29/2004US6756226 Enhanced system for construction of adenovirus vectors
06/29/2004US6756222 Escherichia coli having accession No. PTA 1579 and its use to produce polyhydroxybutyrate
06/29/2004US6756219 Human secretory type phospholipase a2
06/29/2004US6756218 Nucleotide sequences coding enzymatic polypeptide; for amplifying expression of preferential gene product in plant seeds
06/29/2004US6756213 Nucleic acid encoding retinoic acid receptor
06/29/2004US6756212 Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof
06/29/2004US6756211 Neutropohil inhibitors
06/29/2004US6756207 For rapidly determining the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions
06/29/2004US6756203 Assays for compounds that modulate rhadino virus LANA action in trans on a unit of rhadino virus DNA to mediate efficient episome persistence
06/29/2004US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
06/29/2004US6756198 Nucleotide sequences for use in the treatment of and prevention of viral infections
06/29/2004US6756055 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
06/29/2004US6756054 Cholesterol carbamylated to straight chain polyamine
06/29/2004US6756044 Heightening response of immune effector cells
06/29/2004US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects
06/29/2004US6756014 Chemical detector; for use in the detection of preferential particles in solution
06/29/2004CA2307177C Methods for detecting contamination in molecular diagnostics using pcr
06/29/2004CA2294476C Semaphorin receptors
06/29/2004CA2276570C Method of pcr testing of pooled blood samples
06/29/2004CA2131311C Covalently cross-linked oligonucleotides
06/29/2004CA2038669C Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
06/29/2004CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas)
06/27/2004CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue
06/24/2004WO2004053499A1 Fluorescent indicator using fret
06/24/2004WO2004053453A2 Modulation of bub 1-beta expression